Kestra Advisory Services’s Arbutus Biopharma ABUS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$43.3K	Sell	14,000 -48	-0.3%	-$148	﹤0.01%	2772
2025 Q1	$49K	Buy	+14,048	New	+$49K	﹤0.01%	2646
2024 Q3	–	Sell	-10,800	Closed	-$33.4K	–	2536
2024 Q2	$33.4K	Sell	10,800 -223	-2%	-$689	﹤0.01%	2565
2024 Q1	$28.4K	Buy	+11,023	New	+$28.4K	﹤0.01%	2422